Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from TAKARA BIO INC. was processed by Pulse News Wire on May 20, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, May 20 (Pulse News Wire) – TAKARA BIO INC. (4974.T) announced plans to conduct a share consolidation that will result in the company's delisting from the Tokyo Stock Exchange. The company will
View all TAKARA BIO INC. disclosures →
TOKYO, May 20 (Pulse News Wire) – TAKARA BIO INC. (4974.T) announced plans to conduct a share consolidation that will result in the company's delisting from the Tokyo Stock Exchange.
The company will consolidate shares at a ratio of 374:1.
An extraordinary general meeting of shareholders to approve the consolidation is scheduled for May 20, 2026.
The company's shares are expected to be delisted on June 12, 2026.
🟢 Confidence: High AI-translated content.